 | • レポートコード：QFJ1-4912 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、麦粒腫治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、眼科用ステロイド）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・麦粒腫治療薬の市場動向 ・企業の競争状況、市場シェア ・麦粒腫治療薬の種類別市場規模と予測2016-2027（抗生物質、眼科用ステロイド） ・麦粒腫治療薬の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局） ・麦粒腫治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・麦粒腫治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・麦粒腫治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・麦粒腫治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・麦粒腫治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Similasan、Bausch and Lomb、Johnson & Johnson、Novartis AG、Allergan、Daiichi Sankyo、AbbVie Inc、Sun Pharmaceutical Industries Ltd、Merck、Pfizer、XOMA、EyePoint Pharmaceuticals、Enzo Biochem Inc、TopiVert Ltd、Santen Pharmaceutical Co., Ltd、Regeneron Pharmaceuticals Inc） ・結論 |
Stye, also known as hordeolum, is a painful and acute infection on the upper or lower eyelid. Majority of the cases of hordeolum are due to Staphylococcus aureus followed by Staphylococcus epidermidis. All age groups can be affected, although there is a slight increase in prevalence of stye in patients aged between 30 years and 50 years. Stye can be treated with topical ointment or sometimes oral antibiotics. However, in some cases, surgeries are performed. Typically, the size of the swelling is a direct indicator of the severity of the infection. Recurrent of hordeolum is usually due to failure to eliminate the bacteria completely.
Market Analysis and Insights: Global Stye Drugs Market
The global Stye Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Stye Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Stye Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Stye Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Stye Drugs market.
Global Stye Drugs Scope and Market Size
Stye Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Stye Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Distribution Channel in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Antibiotic
Ophthalmic Steroids
Segment by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Similasan
Bausch and Lomb
Johnson & Johnson
Novartis AG
Allergan
Daiichi Sankyo
AbbVie Inc
Sun Pharmaceutical Industries Ltd
Merck
Pfizer
XOMA
EyePoint Pharmaceuticals
Enzo Biochem Inc
TopiVert Ltd
Santen Pharmaceutical Co., Ltd
Regeneron Pharmaceuticals Inc
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stye Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antibiotic
1.2.3 Ophthalmic Steroids
1.3 Market by Application
1.3.1 Global Stye Drugs Market Share by Distribution Channel: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Stye Drugs Market Perspective (2016-2027)
2.2 Stye Drugs Growth Trends by Regions
2.2.1 Stye Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Stye Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Stye Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Stye Drugs Industry Dynamic
2.3.1 Stye Drugs Market Trends
2.3.2 Stye Drugs Market Drivers
2.3.3 Stye Drugs Market Challenges
2.3.4 Stye Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stye Drugs Players by Revenue
3.1.1 Global Top Stye Drugs Players by Revenue (2016-2021)
3.1.2 Global Stye Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Stye Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Stye Drugs Revenue
3.4 Global Stye Drugs Market Concentration Ratio
3.4.1 Global Stye Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stye Drugs Revenue in 2020
3.5 Stye Drugs Key Players Head office and Area Served
3.6 Key Players Stye Drugs Product Solution and Service
3.7 Date of Enter into Stye Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Stye Drugs Breakdown Data by Type
4.1 Global Stye Drugs Historic Market Size by Type (2016-2021)
4.2 Global Stye Drugs Forecasted Market Size by Type (2022-2027)
5 Stye Drugs Breakdown Data by Distribution Channel
5.1 Global Stye Drugs Historic Market Size by Distribution Channel (2016-2021)
5.2 Global Stye Drugs Forecasted Market Size by Distribution Channel (2022-2027)
6 North America
6.1 North America Stye Drugs Market Size (2016-2027)
6.2 North America Stye Drugs Market Size by Type
6.2.1 North America Stye Drugs Market Size by Type (2016-2021)
6.2.2 North America Stye Drugs Market Size by Type (2022-2027)
6.2.3 North America Stye Drugs Market Size by Type (2016-2027)
6.3 North America Stye Drugs Market Size by Distribution Channel
6.3.1 North America Stye Drugs Market Size by Distribution Channel (2016-2021)
6.3.2 North America Stye Drugs Market Size by Distribution Channel (2022-2027)
6.3.3 North America Stye Drugs Market Size by Distribution Channel (2016-2027)
6.4 North America Stye Drugs Market Size by Country
6.4.1 North America Stye Drugs Market Size by Country (2016-2021)
6.4.2 North America Stye Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Stye Drugs Market Size (2016-2027)
7.2 Europe Stye Drugs Market Size by Type
7.2.1 Europe Stye Drugs Market Size by Type (2016-2021)
7.2.2 Europe Stye Drugs Market Size by Type (2022-2027)
7.2.3 Europe Stye Drugs Market Size by Type (2016-2027)
7.3 Europe Stye Drugs Market Size by Distribution Channel
7.3.1 Europe Stye Drugs Market Size by Distribution Channel (2016-2021)
7.3.2 Europe Stye Drugs Market Size by Distribution Channel (2022-2027)
7.3.3 Europe Stye Drugs Market Size by Distribution Channel (2016-2027)
7.4 Europe Stye Drugs Market Size by Country
7.4.1 Europe Stye Drugs Market Size by Country (2016-2021)
7.4.2 Europe Stye Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Stye Drugs Market Size (2016-2027)
8.2 Asia-Pacific Stye Drugs Market Size by Type
8.2.1 Asia-Pacific Stye Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Stye Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Stye Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Stye Drugs Market Size by Distribution Channel
8.3.1 Asia-Pacific Stye Drugs Market Size by Distribution Channel (2016-2021)
8.3.2 Asia-Pacific Stye Drugs Market Size by Distribution Channel (2022-2027)
8.3.3 Asia-Pacific Stye Drugs Market Size by Distribution Channel (2016-2027)
8.4 Asia-Pacific Stye Drugs Market Size by Region
8.4.1 Asia-Pacific Stye Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Stye Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Stye Drugs Market Size (2016-2027)
9.2 Latin America Stye Drugs Market Size by Type
9.2.1 Latin America Stye Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Stye Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Stye Drugs Market Size by Type (2016-2027)
9.3 Latin America Stye Drugs Market Size by Distribution Channel
9.3.1 Latin America Stye Drugs Market Size by Distribution Channel (2016-2021)
9.3.2 Latin America Stye Drugs Market Size by Distribution Channel (2022-2027)
9.3.3 Latin America Stye Drugs Market Size by Distribution Channel (2016-2027)
9.4 Latin America Stye Drugs Market Size by Country
9.4.1 Latin America Stye Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Stye Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stye Drugs Market Size (2016-2027)
10.2 Middle East & Africa Stye Drugs Market Size by Type
10.2.1 Middle East & Africa Stye Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Stye Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Stye Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Stye Drugs Market Size by Distribution Channel
10.3.1 Middle East & Africa Stye Drugs Market Size by Distribution Channel (2016-2021)
10.3.2 Middle East & Africa Stye Drugs Market Size by Distribution Channel (2022-2027)
10.3.3 Middle East & Africa Stye Drugs Market Size by Distribution Channel (2016-2027)
10.4 Middle East & Africa Stye Drugs Market Size by Country
10.4.1 Middle East & Africa Stye Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Stye Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Similasan
11.1.1 Similasan Company Details
11.1.2 Similasan Business Overview
11.1.3 Similasan Stye Drugs Introduction
11.1.4 Similasan Revenue in Stye Drugs Business (2016-2021)
11.1.5 Similasan Recent Development
11.2 Bausch and Lomb
11.2.1 Bausch and Lomb Company Details
11.2.2 Bausch and Lomb Business Overview
11.2.3 Bausch and Lomb Stye Drugs Introduction
11.2.4 Bausch and Lomb Revenue in Stye Drugs Business (2016-2021)
11.2.5 Bausch and Lomb Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Stye Drugs Introduction
11.3.4 Johnson & Johnson Revenue in Stye Drugs Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Stye Drugs Introduction
11.4.4 Novartis AG Revenue in Stye Drugs Business (2016-2021)
11.4.5 Novartis AG Recent Development
11.5 Allergan
11.5.1 Allergan Company Details
11.5.2 Allergan Business Overview
11.5.3 Allergan Stye Drugs Introduction
11.5.4 Allergan Revenue in Stye Drugs Business (2016-2021)
11.5.5 Allergan Recent Development
11.6 Daiichi Sankyo
11.6.1 Daiichi Sankyo Company Details
11.6.2 Daiichi Sankyo Business Overview
11.6.3 Daiichi Sankyo Stye Drugs Introduction
11.6.4 Daiichi Sankyo Revenue in Stye Drugs Business (2016-2021)
11.6.5 Daiichi Sankyo Recent Development
11.7 AbbVie Inc
11.7.1 AbbVie Inc Company Details
11.7.2 AbbVie Inc Business Overview
11.7.3 AbbVie Inc Stye Drugs Introduction
11.7.4 AbbVie Inc Revenue in Stye Drugs Business (2016-2021)
11.7.5 AbbVie Inc Recent Development
11.8 Sun Pharmaceutical Industries Ltd
11.8.1 Sun Pharmaceutical Industries Ltd Company Details
11.8.2 Sun Pharmaceutical Industries Ltd Business Overview
11.8.3 Sun Pharmaceutical Industries Ltd Stye Drugs Introduction
11.8.4 Sun Pharmaceutical Industries Ltd Revenue in Stye Drugs Business (2016-2021)
11.8.5 Sun Pharmaceutical Industries Ltd Recent Development
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Merck Business Overview
11.9.3 Merck Stye Drugs Introduction
11.9.4 Merck Revenue in Stye Drugs Business (2016-2021)
11.9.5 Merck Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Stye Drugs Introduction
11.10.4 Pfizer Revenue in Stye Drugs Business (2016-2021)
11.10.5 Pfizer Recent Development
11.11 XOMA
11.11.1 XOMA Company Details
11.11.2 XOMA Business Overview
11.11.3 XOMA Stye Drugs Introduction
11.11.4 XOMA Revenue in Stye Drugs Business (2016-2021)
11.11.5 XOMA Recent Development
11.12 EyePoint Pharmaceuticals
11.12.1 EyePoint Pharmaceuticals Company Details
11.12.2 EyePoint Pharmaceuticals Business Overview
11.12.3 EyePoint Pharmaceuticals Stye Drugs Introduction
11.12.4 EyePoint Pharmaceuticals Revenue in Stye Drugs Business (2016-2021)
11.12.5 EyePoint Pharmaceuticals Recent Development
11.13 Enzo Biochem Inc
11.13.1 Enzo Biochem Inc Company Details
11.13.2 Enzo Biochem Inc Business Overview
11.13.3 Enzo Biochem Inc Stye Drugs Introduction
11.13.4 Enzo Biochem Inc Revenue in Stye Drugs Business (2016-2021)
11.13.5 Enzo Biochem Inc Recent Development
11.14 TopiVert Ltd
11.14.1 TopiVert Ltd Company Details
11.14.2 TopiVert Ltd Business Overview
11.14.3 TopiVert Ltd Stye Drugs Introduction
11.14.4 TopiVert Ltd Revenue in Stye Drugs Business (2016-2021)
11.14.5 TopiVert Ltd Recent Development
11.15 Santen Pharmaceutical Co., Ltd
11.15.1 Santen Pharmaceutical Co., Ltd Company Details
11.15.2 Santen Pharmaceutical Co., Ltd Business Overview
11.15.3 Santen Pharmaceutical Co., Ltd Stye Drugs Introduction
11.15.4 Santen Pharmaceutical Co., Ltd Revenue in Stye Drugs Business (2016-2021)
11.15.5 Santen Pharmaceutical Co., Ltd Recent Development
11.16 Regeneron Pharmaceuticals Inc
11.16.1 Regeneron Pharmaceuticals Inc Company Details
11.16.2 Regeneron Pharmaceuticals Inc Business Overview
11.16.3 Regeneron Pharmaceuticals Inc Stye Drugs Introduction
11.16.4 Regeneron Pharmaceuticals Inc Revenue in Stye Drugs Business (2016-2021)
11.16.5 Regeneron Pharmaceuticals Inc Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Stye Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antibiotic
Table 3. Key Players of Ophthalmic Steroids
Table 4. Global Stye Drugs Market Size Growth by Distribution Channel (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Stye Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Stye Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Stye Drugs Market Share by Regions (2016-2021)
Table 8. Global Stye Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Stye Drugs Market Share by Regions (2022-2027)
Table 10. Stye Drugs Market Trends
Table 11. Stye Drugs Market Drivers
Table 12. Stye Drugs Market Challenges
Table 13. Stye Drugs Market Restraints
Table 14. Global Stye Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Stye Drugs Market Share by Players (2016-2021)
Table 16. Global Top Stye Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stye Drugs as of 2020)
Table 17. Ranking of Global Top Stye Drugs Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Stye Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Stye Drugs Product Solution and Service
Table 21. Date of Enter into Stye Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Stye Drugs Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Stye Drugs Revenue Market Share by Type (2016-2021)
Table 25. Global Stye Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Stye Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Stye Drugs Market Size Share by Distribution Channel (2016-2021) & (US$ Million)
Table 28. Global Stye Drugs Revenue Market Share by Distribution Channel (2016-2021)
Table 29. Global Stye Drugs Forecasted Market Size by Distribution Channel (2022-2027) (US$ Million)
Table 30. Global Stye Drugs Revenue Market Share by Distribution Channel (2022-2027) & (US$ Million)
Table 31. North America Stye Drugs Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Stye Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Stye Drugs Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 34. North America Stye Drugs Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 35. North America Stye Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Stye Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Stye Drugs Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Stye Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Stye Drugs Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 40. Europe Stye Drugs Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 41. Europe Stye Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Stye Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Stye Drugs Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Stye Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Stye Drugs Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 46. Asia-Pacific Stye Drugs Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Stye Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Stye Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Stye Drugs Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Stye Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Stye Drugs Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 52. Latin America Stye Drugs Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 53. Latin America Stye Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Stye Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Stye Drugs Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Stye Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Stye Drugs Market Size by Distribution Channel (2016-2021) (US$ Million)
Table 58. Middle East & Africa Stye Drugs Market Size by Distribution Channel (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Stye Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Stye Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 61. Similasan Company Details
Table 62. Similasan Business Overview
Table 63. Similasan Stye Drugs Product
Table 64. Similasan Revenue in Stye Drugs Business (2016-2021) & (US$ Million)
Table 65. Similasan Recent Development
Table 66. Bausch and Lomb Company Details
Table 67. Bausch and Lomb Business Overview
Table 68. Bausch and Lomb Stye Drugs Product
Table 69. Bausch and Lomb Revenue in Stye Drugs Business (2016-2021) & (US$ Million)
Table 70. Bausch and Lomb Recent Development
Table 71. Johnson & Johnson Company Details
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Stye Drugs Product
Table 74. Johnson & Johnson Revenue in Stye Drugs Business (2016-2021) & (US$ Million)
Table 75. Johnson & Johnson Recent Development
Table 76. Novartis AG Company Details
Table 77. Novartis AG Business Overview
Table 78. Novartis AG Stye Drugs Product
Table 79. Novartis AG Revenue in Stye Drugs Business (2016-2021) & (US$ Million)
Table 80. Novartis AG Recent Development
Table 81. Allergan Company Details
Table 82. Allergan Business Overview
Table 83. Allergan Stye Drugs Product
Table 84. Allergan Revenue in Stye Drugs Business (2016-2021) & (US$ Million)
Table 85. Allergan Recent Development
Table 86. Daiichi Sankyo Company Details
Table 87. Daiichi Sankyo Business Overview
Table 88. Daiichi Sankyo Stye Drugs Product
Table 89. Daiichi Sankyo Revenue in Stye Drugs Business (2016-2021) & (US$ Million)
Table 90. Daiichi Sankyo Recent Development
Table 91. AbbVie Inc Company Details
Table 92. AbbVie Inc Business Overview
Table 93. AbbVie Inc Stye Drugs Product
Table 94. AbbVie Inc Revenue in Stye Drugs Business (2016-2021) & (US$ Million)
Table 95. AbbVie Inc Recent Development
Table 96. Sun Pharmaceutical Industries Ltd Company Details
Table 97. Sun Pharmaceutical Industries Ltd Business Overview
Table 98. Sun Pharmaceutical Industries Ltd Revenue in Stye Drugs Business (2016-2021) & (US$ Million)
Table 99. Sun Pharmaceutical Industries Ltd Recent Development
Table 100. Merck Company Details
Table 101. Merck Business Overview
Table 102. Merck Stye Drugs Product
Table 103. Merck Revenue in Stye Drugs Business (2016-2021) & (US$ Million)
Table 104. Merck Recent Development
Table 105. Pfizer Company Details
Table 106. Pfizer Business Overview
Table 107. Pfizer Stye Drugs Product
Table 108. Pfizer Revenue in Stye Drugs Business (2016-2021) & (US$ Million)
Table 109. Pfizer Recent Development
Table 110. XOMA Company Details
Table 111. XOMA Business Overview
Table 112. XOMA Stye Drugs Product
Table 113. XOMA Revenue in Stye Drugs Business (2016-2021) & (US$ Million)
Table 114. XOMA Recent Development
Table 115. EyePoint Pharmaceuticals Company Details
Table 116. EyePoint Pharmaceuticals Business Overview
Table 117. EyePoint Pharmaceuticals Stye Drugs Product
Table 118. EyePoint Pharmaceuticals Revenue in Stye Drugs Business (2016-2021) & (US$ Million)
Table 119. EyePoint Pharmaceuticals Recent Development
Table 120. Enzo Biochem Inc Company Details
Table 121. Enzo Biochem Inc Business Overview
Table 122. Enzo Biochem Inc Stye Drugs Product
Table 123. Enzo Biochem Inc Revenue in Stye Drugs Business (2016-2021) & (US$ Million)
Table 124. Enzo Biochem Inc Recent Development
Table 125. TopiVert Ltd Company Details
Table 126. TopiVert Ltd Business Overview
Table 127. TopiVert Ltd Stye Drugs Product
Table 128. TopiVert Ltd Revenue in Stye Drugs Business (2016-2021) & (US$ Million)
Table 129. TopiVert Ltd Recent Development
Table 130. Santen Pharmaceutical Co., Ltd Company Details
Table 131. Santen Pharmaceutical Co., Ltd Business Overview
Table 132. Santen Pharmaceutical Co., Ltd Stye Drugs Product
Table 133. Santen Pharmaceutical Co., Ltd Revenue in Stye Drugs Business (2016-2021) & (US$ Million)
Table 134. Santen Pharmaceutical Co., Ltd Recent Development
Table 135. Regeneron Pharmaceuticals Inc Company Details
Table 136. Regeneron Pharmaceuticals Inc Business Overview
Table 137. Regeneron Pharmaceuticals Inc Stye Drugs Product
Table 138. Regeneron Pharmaceuticals Inc Revenue in Stye Drugs Business (2016-2021) & (US$ Million)
Table 139. Regeneron Pharmaceuticals Inc Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Stye Drugs Market Share by Type: 2020 VS 2027
Figure 2. Antibiotic Features
Figure 3. Ophthalmic Steroids Features
Figure 4. Global Stye Drugs Market Share by Distribution Channel: 2020 VS 2027
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Stye Drugs Report Years Considered
Figure 9. Global Stye Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Stye Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Stye Drugs Market Share by Regions: 2020 VS 2027
Figure 12. Global Stye Drugs Market Share by Regions (2022-2027)
Figure 13. Global Stye Drugs Market Share by Players in 2020
Figure 14. Global Top Stye Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Stye Drugs as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Stye Drugs Revenue in 2020
Figure 16. Global Stye Drugs Revenue Market Share by Type (2016-2021)
Figure 17. Global Stye Drugs Revenue Market Share by Type (2022-2027)
Figure 18. North America Stye Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Stye Drugs Market Share by Type (2016-2027)
Figure 20. North America Stye Drugs Market Share by Distribution Channel (2016-2027)
Figure 21. North America Stye Drugs Market Share by Country (2016-2027)
Figure 22. United States Stye Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Stye Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Stye Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Stye Drugs Market Share by Type (2016-2027)
Figure 26. Europe Stye Drugs Market Share by Distribution Channel (2016-2027)
Figure 27. Europe Stye Drugs Market Share by Country (2016-2027)
Figure 28. Germany Stye Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Stye Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Stye Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Stye Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Stye Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Stye Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Stye Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Stye Drugs Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Stye Drugs Market Share by Distribution Channel (2016-2027)
Figure 37. Asia-Pacific Stye Drugs Market Share by Region (2016-2027)
Figure 38. China Stye Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Stye Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Stye Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Stye Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Stye Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Stye Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Stye Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Stye Drugs Market Share by Type (2016-2027)
Figure 46. Latin America Stye Drugs Market Share by Distribution Channel (2016-2027)
Figure 47. Latin America Stye Drugs Market Share by Country (2016-2027)
Figure 48. Mexico Stye Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Stye Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Stye Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Stye Drugs Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Stye Drugs Market Share by Distribution Channel (2016-2027)
Figure 53. Middle East & Africa Stye Drugs Market Share by Country (2016-2027)
Figure 54. Turkey Stye Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Stye Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Stye Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Similasan Revenue Growth Rate in Stye Drugs Business (2016-2021)
Figure 58. Bausch and Lomb Revenue Growth Rate in Stye Drugs Business (2016-2021)
Figure 59. Johnson & Johnson Revenue Growth Rate in Stye Drugs Business (2016-2021)
Figure 60. Novartis AG Revenue Growth Rate in Stye Drugs Business (2016-2021)
Figure 61. Allergan Revenue Growth Rate in Stye Drugs Business (2016-2021)
Figure 62. Daiichi Sankyo Revenue Growth Rate in Stye Drugs Business (2016-2021)
Figure 63. AbbVie Inc Revenue Growth Rate in Stye Drugs Business (2016-2021)
Figure 64. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Stye Drugs Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in Stye Drugs Business (2016-2021)
Figure 66. Pfizer Revenue Growth Rate in Stye Drugs Business (2016-2021)
Figure 67. XOMA Revenue Growth Rate in Stye Drugs Business (2016-2021)
Figure 68. EyePoint Pharmaceuticals Revenue Growth Rate in Stye Drugs Business (2016-2021)
Figure 69. Enzo Biochem Inc Revenue Growth Rate in Stye Drugs Business (2016-2021)
Figure 70. TopiVert Ltd Revenue Growth Rate in Stye Drugs Business (2016-2021)
Figure 71. Santen Pharmaceutical Co., Ltd Revenue Growth Rate in Stye Drugs Business (2016-2021)
Figure 72. Regeneron Pharmaceuticals Inc Revenue Growth Rate in Stye Drugs Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の体部白癬治療薬市場規模・現状・予測（2021年-2027年） Tinea corporis, also known as ringworm, is a superficial fungal infection (dermatophytosis) of the arms and legs, especially on glabrous skin; however, it may occur on any part of the body. It is similar to other forms of tinea. Market Analysis and Insights: Global Tinea Corporis Drugs Market The gl…- 世界のβ-ラクタム系薬剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Beta-Lactam Drugs Market The global Beta-Lactam Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a…
- 世界の心理療法薬市場規模・現状・予測（2021年-2027年） Psychotherapy is a collaborative approach used by psychologists to help people overcome various mental illnesses and emotional difficulties. Market Analysis and Insights: Global Psychotherapeutic Drugs Market The global Psychotherapeutic Drugs market size is projected to reach US$ XX million by 2027…
- 世界のウイルス性肺炎治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Viral Pneumonia Treatment Drugs Market The global Viral Pneumonia Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data i…
- 世界のインスリン非依存型糖尿病治療薬市場規模・現状・予測（2021年-2027年） Diabetes is a metabolic disease, wherein the body is either unable to secret insulin (type 1 diabetes) or is unable to utilize the generated insulin (type 2 diabetes). Market Analysis and Insights: Global Non Insulin Anti diabetes Drugs Market The global Non Insulin Anti diabetes Drugs market size i…